gemcitabine has been researched along with Carcinoma, Medullary in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albiges, L; Allory, Y; Auclin, E; Barthelemy, P; Brihoum, M; Chevreau, C; Coquan, E; de Reyniès, A; Elaidi, RT; Fléchon, A; Gravis, G; Gross-Goupil, M; Joly, C; Laguerre, B; Oudard, S; Pécuchet, N; Rolland, F; Thibault, C; Timsit, MO | 1 |
| Akyol, M; Alacacioglu, A; Bayoglu, V; Can, A; Demir, L; Dirican, A; Erten, C; Kucukzeybek, Y; Somali, I; Tarhan, MO | 1 |
| Alazraki, A; Carden, MA; Meany, H; Rapkin, LB; Smith, S; Yin, H | 1 |
| Hsiao, PJ; Hung, WW; Ou-Yang, F; Shin, SJ; Tsai, KB; Wang, CS | 1 |
| Bockisch, A; Dralle, H; Kegel, T; Mann, K; Matuszczyk, A; Petersenn, S; Schmoll, HJ; Voigt, W | 1 |
| Abbou, CC; De La Taille, A; Diao, B; Esquivel, S; Paule, B; Salomon, L | 1 |
| Debré, B; Oudard, S; Peyromaure, M; Scotté, F; Thiounn, N; Vieillefond, A | 1 |
| Cajozzo, M; Comella, G; Condemi, G; Danova, M; De Cataldis, G; Farris, A; Ferraù, F; Filippelli, G; Iannitto, E; Leonardi, V; Macaluso, MC; Mangiameli, A; Massidda, B; Misino, A; Palmeri, L; Palmeri, S; Spada, S; Vaglica, M | 1 |
| Bell, MD | 1 |
| Azzadin, A; Chyczewski, L; Dadan, J; Dziecioł, J; Puchalski, Z; Sawicki, B; Wołczyński, S | 1 |
2 review(s) available for gemcitabine and Carcinoma, Medullary
| Article | Year |
|---|---|
[Renal medullary carcinoma: remission with gemcitabine-cisplatin and review of therapeutic perspectives].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Remission Induction | 2010 |
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Survival Rate; Taxoids; Treatment Outcome | 2005 |
3 trial(s) available for gemcitabine and Carcinoma, Medullary
| Article | Year |
|---|---|
Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Medullary; Carcinoma, Renal Cell; Gemcitabine; Humans; Hypertension; Kidney; Kidney Neoplasms; Platinum; Prospective Studies; Retrospective Studies | 2023 |
Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epithelium.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Medullary; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Thyroid Neoplasms | 2010 |
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Survival Rate; Taxoids; Treatment Outcome | 2005 |
6 other study(ies) available for gemcitabine and Carcinoma, Medullary
| Article | Year |
|---|---|
Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate | 2013 |
Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases.
Topics: Adolescent; Anemia, Sickle Cell; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Carcinoma, Medullary; Child; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Paclitaxel | 2017 |
Medullary thyroid carcinoma with poor differentiation and atypical radiographic pattern of metastasis.
Topics: Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy, Fine-Needle; Calcitonin; Carcinoma, Medullary; Chromogranin A; Deoxycytidine; Diagnosis, Differential; Gemcitabine; Humans; Lung Neoplasms; Male; Radiography, Thoracic; Synaptophysin; Thyroid Neoplasms; Thyroidectomy | 2009 |
Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Neoplasms; Kidney Tubules, Collecting; Male; Middle Aged; Neoplasm Staging | 2003 |
Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Cisplatin; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Kidney Medulla; Kidney Neoplasms; Male; Paclitaxel | 2006 |
Preliminary evaluation of influence of gemcitabine (Gemzar) on proliferation and neuroendocrine activity of human TT cell line: immunocytochemical investigations.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Medullary; Cell Division; Cell Survival; Deoxycytidine; Gemcitabine; Humans; Immunohistochemistry; Neurosecretory Systems; Thyroid Neoplasms; Tumor Cells, Cultured | 2001 |